{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:04:15Z","timestamp":1765667055429},"reference-count":67,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.clinthera.2013.05.011","type":"journal-article","created":{"date-parts":[[2013,7,19]],"date-time":"2013-07-19T01:58:00Z","timestamp":1374199080000},"page":"967-984.e2","source":"Crossref","is-referenced-by-count":36,"title":["Mixed Treatment Comparison Meta-Analysis of Aspirin, Warfarin, and New Anticoagulants for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation"],"prefix":"10.1016","volume":"35","author":[{"given":"Abdullah","family":"Assiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Al-Majzoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abir O.","family":"Kanaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2013.05.011_bib1","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2013.05.011_bib2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/heart.86.5.516","article-title":"Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew\/Paisley study","volume":"86","author":"Stewart","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.clinthera.2013.05.011_bib3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5694\/j.1326-5377.2002.tb04430.x","article-title":"The Avoid Stroke as Soon as Possible (ASAP) general practice stroke audit","volume":"176","author":"Sturm","year":"2002","journal-title":"Med J Aust"},{"key":"10.1016\/j.clinthera.2013.05.011_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/AC.67.1.2146567","article-title":"Prevalence of atrial fibrillation in Greece: the Arcadia Rural Study on Atrial Fibrillation","volume":"67","author":"Ntaios","year":"2012","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.clinthera.2013.05.011_bib5","doi-asserted-by":"crossref","first-page":"e415","DOI":"10.1161\/STROKEAHA.108.535724","article-title":"Ischemic stroke in South Asians: a review of the epidemiology, pathophysiology, and ethnicity-related clinical features","volume":"40","author":"Gunarathne","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2013.05.011_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3346\/jkms.2005.20.1.26","article-title":"Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years","volume":"20","author":"Jeong","year":"2005","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.clinthera.2013.05.011_bib7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/CIRCEP.112.970749","article-title":"Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry","volume":"5","author":"Chiang","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.clinthera.2013.05.011_bib8","doi-asserted-by":"crossref","unstructured":"Ohsawa M,Okayama A, Sakata K, et al. Rapid increase in estimated number of persons with atrial fibrillation in Japan: an analysis from national surveys on cardiovascular diseases in 1980, 1990 and 2000. J Epidemiol. 2005;15:194\u2013196.","DOI":"10.2188\/jea.15.194"},{"key":"10.1016\/j.clinthera.2013.05.011_bib9","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1378\/chest.11-2888","article-title":"The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe","volume":"142","author":"Lip","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2013.05.011_bib10","unstructured":"Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med. 11 1994;154:1449\u20131457"},{"key":"10.1016\/j.clinthera.2013.05.011_bib11","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00277-011-1267-3","article-title":"Risk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rules","volume":"90","author":"Loewen","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clinthera.2013.05.011_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","volume":"57","author":"Lip","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2013.05.011_bib13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1160\/TH08-03-0193","article-title":"Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry","volume":"100","author":"Ruiz-Gimenez","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinthera.2013.05.011_bib14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jacc.2011.03.031","article-title":"A new risk scheme to predict warfarin-associated hemorrhage: the ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study","volume":"58","author":"Fang","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2013.05.011_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/eurheartj\/ehp434","article-title":"Correlation of inhibition of platelet aggregation after clopidogrel with post discharge bleeding events: assessment by different bleeding classifications","volume":"31","author":"Serebruany","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2013.05.011_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/STR.0b013e3181f7d043","article-title":"Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Furie","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2013.05.011_bib17","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1161\/STR.0b013e318266722a","article-title":"Oral antithrombotic agents for the prevention of stroke in nonvalvular atrial fibrillation: a science advisory for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"43","author":"Furie","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2013.05.011_bib18","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2013.05.011_bib19","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","article-title":"Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin","volume":"110","author":"Gage","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2013.05.011_bib20","doi-asserted-by":"crossref","unstructured":"Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke. 2008;39:1901\u20131910","DOI":"10.1161\/STROKEAHA.107.501825"},{"key":"10.1016\/j.clinthera.2013.05.011_bib21","doi-asserted-by":"crossref","first-page":"831","DOI":"10.7326\/0003-4819-138-10-200305200-00011","article-title":"Lessons from the Stroke Prevention in Atrial Fibrillation trials","volume":"138","author":"Hart","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2013.05.011_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"Suppl","key":"10.1016\/j.clinthera.2013.05.011_bib23","doi-asserted-by":"crossref","first-page":"e531S","DOI":"10.1378\/chest.11-2304","article-title":"Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"You","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2013.05.011_bib24","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/archinte.166.12.1269","article-title":"Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation","volume":"166","author":"Cooper","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2013.05.011_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.clinthera.2013.05.011_bib26","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1002\/sim.1875","article-title":"Combination of direct and indirect evidence in mixed treatment comparisons","volume":"23","author":"Lu","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.clinthera.2013.05.011_bib27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1198\/016214505000001302","article-title":"Assessing evidence inconsistency in mixed treatment comparisons","volume":"101","author":"Lu","year":"2006","journal-title":"J Am Statist Assoc"},{"key":"10.1016\/j.clinthera.2013.05.011_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2288-10-54","article-title":"Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial","volume":"10","author":"Woods","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.clinthera.2013.05.011_bib29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.dss.2012.10.005","article-title":"ADDIS: a decision support system for evidence-based medicine","volume":"55","author":"van Valkenhoef","year":"2012","journal-title":"Decision Support Systems"},{"key":"10.1016\/j.clinthera.2013.05.011_bib30","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/bmj.331.7521.897","article-title":"Simultaneous comparison of multiple treatments: combining direct and indirect evidence","volume":"331","author":"Caldwell","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2013.05.011_bib31","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/sim.1201","article-title":"Network meta-analysis for indirect treatment comparisons","volume":"21","author":"Lumley","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.clinthera.2013.05.011_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/0962280207080643","article-title":"Evaluation of networks of randomized trials","volume":"17","author":"Salanti","year":"2008","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/j.clinthera.2013.05.011_bib33","doi-asserted-by":"crossref","first-page":"544","DOI":"10.7326\/0003-4819-148-7-200804010-00011","article-title":"Exploring the geometry of treatment networks","volume":"148","author":"Salanti","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2013.05.011_bib34","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.clinthera.2013.05.011_bib35","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study","volume":"1","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2013.05.011_bib36","doi-asserted-by":"crossref","unstructured":"Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation. 1991;84:527\u2013539","DOI":"10.1161\/01.CIR.84.2.527"},{"key":"10.1016\/j.clinthera.2013.05.011_bib37","doi-asserted-by":"crossref","unstructured":"Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet. 1994;343:687\u2013691","DOI":"10.1016\/S0140-6736(94)91577-6"},{"key":"10.1016\/j.clinthera.2013.05.011_bib38","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJM199211123272002","article-title":"Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators","volume":"327","author":"Ezekowitz","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2013.05.011_bib39","doi-asserted-by":"crossref","unstructured":"Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet. 1993;342:1255\u20131262","DOI":"10.1016\/0140-6736(93)92358-Z"},{"issue":"1 Pt 1","key":"10.1016\/j.clinthera.2013.05.011_bib40","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0002-8703(99)70259-0","article-title":"Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group","volume":"138","author":"Posada","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinthera.2013.05.011_bib41","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2796.2003.01159.x","article-title":"Effects of low-dose warfarin and aspirin versus no treatment on stroke in a medium-risk patient population with atrial fibrillation","volume":"254","author":"Edvardsson","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.clinthera.2013.05.011_bib42","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2013.05.011_bib43","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/01.STR.0000198839.61112.ee","article-title":"Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial","volume":"37","author":"Sato","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.clinthera.2013.05.011_bib44","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.amjcard.2007.06.034","article-title":"Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study)","volume":"100","author":"Ezekowitz","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2013.05.011_bib45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2013.05.011_bib46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ageing\/afl129","article-title":"A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)","volume":"36","author":"Rash","year":"2007","journal-title":"Age Ageing"},{"key":"10.1016\/j.clinthera.2013.05.011_bib47","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2013.05.011_bib48","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2013.05.011_bib49","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1160\/TH10-01-0066","article-title":"Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation","volume":"104","author":"Weitz","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinthera.2013.05.011_bib50","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2013.05.011_bib51","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1160\/TH10-07-0451","article-title":"Safety of edoxaban, an oral factor Xa inhibitor, in Asian patients with non-valvular atrial fibrillation","volume":"105","author":"Chung","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.clinthera.2013.05.011_bib52","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2013.05.011_bib53","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1253\/circj.CJ-10-1183","article-title":"Safety and efficacy of the oral direct factor xa inhibitor apixaban in Japanese patients with non-valvular atrial fibrillation. The ARISTOTLE-J study","volume":"75","author":"Ogawa","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.clinthera.2013.05.011_bib54","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2013.05.011_bib55","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1253\/circj.CJ-11-1140","article-title":"Randomized, multicenter, warfarin-controlled phase II study of edoxaban in Japanese patients with non-valvular atrial fibrillation","volume":"76","author":"Yamashita","year":"2012","journal-title":"Circ J"},{"key":"10.1016\/j.clinthera.2013.05.011_bib56","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","article-title":"Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis","volume":"131","author":"Hart","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2013.05.011_bib57","first-page":"CD001925","article-title":"Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks","volume":"4","author":"Aguilar","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2013.05.011_bib58","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2013.05.011_bib59","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1525-1497.2000.04329.x","article-title":"Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs","volume":"15","author":"Segal","year":"2000","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.clinthera.2013.05.011_bib60","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1378\/chest.126.6.1938","article-title":"Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and meta analysis","volume":"126","author":"Reynolds","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2013.05.011_bib61","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijcard.2009.11.045","article-title":"Antithrombotic treatment for the primary prevention of stroke in patients with non valvular atrial fibrillation: a reappraisal of the evidence and network meta analysis","volume":"142","author":"Owen","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinthera.2013.05.011_bib62","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1161\/CIRCULATIONAHA.112.115410","article-title":"Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature","volume":"126","author":"Dentali","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2013.05.011_bib63","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1378\/chest.129.5.1155","article-title":"Effect of study setting on anticoagulation control: a systematic review and metaregression","volume":"129","author":"van Walraven","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2013.05.011_bib64","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.107.750000","article-title":"Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range","volume":"118","author":"Connolly","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2013.05.011_bib65","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1161\/CIR.0b013e318214876d","volume":"123","author":"Fuster","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2013.05.011_bib66","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1378\/chest.127.5.1515","article-title":"Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy","volume":"127","author":"Witt","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.clinthera.2013.05.011_bib67","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11239-006-9022-7","article-title":"Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the International Study of Anticoagulation Management (ISAM)","volume":"23","author":"Ansell","year":"2007","journal-title":"J Thromb Thrombolysis"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813002579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813002579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T06:20:31Z","timestamp":1596176431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291813002579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0149291813002579"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2013.05.011","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}